US COVID-19 booster plan leaves some experts divided

The evidence behind a federal plan to rollout COVID-19 vaccine booster shots to Americans beginning the week of Sept. 20, pending FDA review, has left some experts divided.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.